Search Clinical Trials
Completed
Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal (External Link)
This study is a Phase 2A, randomized, double-blinded, placebo-controlled, two-period crossover study to evaluate the effect of two doses of SXC-2023 on measures of impulsivity and inhibitory control, urge for …
Baylor Role:
Collaborator